EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/06/2025
Voltar para busca
Dado oficial do USPTO
NEURORX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEURORX
ST13
US500000090351677Classe
9, 10, 38, 42, 44
Pedido
90351677
Registro
7082877
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
13/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 38, 42, 44
Data de depósito
01/12/2020
Data de registro
20/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/06/2023
Última transação
13/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
31/12/2013
Primeiro uso no comércio
31/12/2013
Código do desenho
4
Tipo de titular
03
Localização do titular
MONTREAL, CA
Examinador
CLAYTON, CHERYL
Unidade examinadora
L20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
16144233 CANADA INC.
RECHERCHE NEURORX INC.
Representantes
David M. Kramer Buchanan Ingersoll & Rooney P.C.
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
(Based on Use in Commerce) (Based on 44(e)) Downloadable computer software used for radiology information management; Downloadable computer softwaresoftware that permits user to deliver medical imaging functions over a global computer network or internal corporate computer networks; Downloadable computer softwarecomputer filing and database software to storemanipulatetrackschedule and distribute patient information; Downloadable computer softwarecomputer filing and database software to managestoremanipulate and distribute radiological information and imagery; Downloadable computer softwaresoftware that delivers the ability to managestoremanipulate and distribute radiological information and imagery over a global computer network or internal corporate computer networks; Downloadable medical imaging software and medical image co-registration software; Downloadable computer software used for transmittingstoringarchivingdisplaying medical imaging studiesfor creatingmanagingdistributing reports for such studies
Classe 10
(Based on 44(e)) Medical deviceradiology reader that allows the viewing and manipulation of medical images
Classe 38
(Based on Use in Commerce) (Based on 44(e)) Transmission of medical imaging studies via the Internet
Classe 42
(Based on Use in Commerce) (Based on 44(e)) Electronic storage services for archiving medical imaging studiesfeaturing an ability to track and report for such studies for others; Providing a website that gives authorized computer users the ability to upload medical imagesaccess the functions of medical imaging software contained on the website; Researchdesign and development of medical imaging software; Providing temporary use of non-downloadable medical imaging software for limited usage; Computer project management services; technology supervision of MRI facilities participating in clinical trials; software as a service featuring software for automated standardizationcollectioninterpretation and analysis of medical images
Classe 44
(Based on Use in Commerce) (Based on 44(e)) Consulting services in the field of medical imaging regarding imaging outcome measures to support drug development
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/06/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/06/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/06/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
20/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/03/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
24/02/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/02/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
24/02/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/02/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
24/01/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
20/12/2022
EXPT
EXPARTE APPEAL TERMINATED
05/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2022
DMCC
DATA MODIFICATION COMPLETED
05/12/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/12/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/12/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/12/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/12/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
09/11/2022
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
02/09/2022
GECD
ACTION DENYING REQ FOR RECON E-MAILED
02/09/2022
CNCF
ACTION CONTINUING FINAL - COMPLETED
02/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2022
ALIE
ASSIGNED TO LIE
12/07/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/07/2022
EXPI
EX PARTE APPEAL-INSTITUTED
05/07/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/07/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
05/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/01/2022
GNFR
FINAL REFUSAL E-MAILED
05/01/2022
CNFR
FINAL REFUSAL WRITTEN
05/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/05/2021
GNRT
NON-FINAL ACTION E-MAILED
24/05/2021
CNRT
NON-FINAL ACTION WRITTEN
24/05/2021
DOCK
ASSIGNED TO EXAMINER
17/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
04/12/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/12/2020
NWAP
NEW APPLICATION ENTERED
04/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEURORX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.